EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Wang Jiale, Liu Longcheng, Lu Peipei, Ma Lihong

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70512 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective The C‐reactive protein‐triglyceride glucose index (CTI) has been associated with cardiovascular risk. This study evaluated its prognostic value for repeat revascularization and in‐stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI). Methods A total of 2147 CCS patients undergoing PCI were stratified into CTI tertiles. The primary endpoint was a composite of repeat revascularization and ISR. Kaplan–Meier analysis with log‐rank tests was used to compare event rates. Multivariable Cox proportional hazards models and restricted cubic spline analyses were applied to assess associations. Predictive performance was evaluated using time‐dependent receiver operating characteristic curves. Results During a median follow‐up of 60 months, 992 patients (46.2%) experienced the primary endpoint. Event rates increased progressively across CTI tertiles. After multivariable adjustment, CTI remained independently associated with the primary endpoint (HR 1.11; 95% CI 1.01–1.22; p = 0.028). Compared with the lowest tertile, the highest CTI tertile was associated with a 31% higher risk (HR 1.31; 95% CI 1.10−1.55; p = 0.002). A linear dose–response relationship was observed ( p for non‐linearity = 0.172; p overall = 0.040). The multivariable model incorporating CTI showed modest discrimination, with AUCs of 0.627 (95% CI 0.602–0.651) at 3 years and 0.651 (95% CI 0.627–0.674) at 5 years. Conclusions CTI is independently associated with increased risks of repeat revascularization and ISR after PCI in patients with CCS. However, its incremental predictive value beyond conventional risk factors appears limited and requires further validation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →